Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy

scientific article published on April 2001

Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11327250

P2093author name stringBorba EF
Bonfá E
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectchloroquineQ422438
P304page(s)780-785
P577publication date2001-04-01
P1433published inThe Journal of RheumatologyQ7743623
P1476titleLongterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy
P478volume28

Reverse relations

cites work (P2860)
Q34389286A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role
Q82662437Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches
Q41939554Antimalarials. A treatment option for every lupus patient!?
Q34938841Aortic Atherosclerosis in Systemic Lupus Erythematosus
Q37319989Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings
Q37425906Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors
Q55208303Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis.
Q26741266Current and emerging treatment options in the management of lupus
Q34648851Current and novel therapeutics in the treatment of systemic lupus erythematosus
Q35188363Decreased high-density lipoprotein cholesterol levels in polyarticular juvenile idiopathic arthritis.
Q36126483Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus
Q96231744Efficacy and safety of chloroquine plus prednisone for the treatment of autoimmune hepatitis in a randomized trial
Q45983994Excess weight and associated risk factors in patients with systemic lupus erythematosus.
Q28548561Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease
Q64227620Impact of antimalarial (AM) on serum lipids in systemic lupus erythematosus (SLE) patients: A systematic review and meta-analysis
Q64946853Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients.
Q45256816Lipoprotein profile in limited systemic sclerosis.
Q39608521Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome
Q38026787New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.
Q35148630Novel Approaches to Therapy for SLE.
Q38156069Pragmatic approaches to therapy for systemic lupus erythematosus
Q94672281The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
Q37947108The role of antimalarial agents in the treatment of SLE and lupus nephritis
Q38271125Treatment of severe lupus nephritis: the new horizon.

Search more.